Nonarteritic ischemic optic neuropathy (NAION) is one of the most prevalent optic nerve disorders seen in ophthalmic practice. The role of corticosteroid therapy in NAION remains a highly controversial area of debate in ophthalmology. This brief review will provide an overview of the current clinical evidence on this topic as well as some comment on the medical debate.
- steroid in nonarteritic ischemic optic neuropathy
- systemic corticosteroid in nonarteritic ischemic optic neuropathy
ASJC Scopus subject areas